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Abstract
RNA interference (RNAi) is a mechanism for inhibiting gene expression through the action of small, non-coding RNAs. Most
existing RNAi libraries target single genes through canonical pathways. Endogenous microRNAs (miRNAs), however, often
target multiple genes and can act through non-canonical pathways, including pathways that activate gene expression. To
interrogate all possible functions, we designed, synthesized, and validated the first shRNA-encoding library that is
completely random at the nucleotide level. Screening in an IL3-dependent cell line, FL5.12, yielded shRNA-encoding
sequences that double cell survival upon IL3 withdrawal. Using random mutagenesis and re-screening under more stringent
IL3-starvation conditions, we hit-optimized one of the sequences; a specific nucleotide change and the creation of a
mismatch between the two halves of the stem both contributed to the improved potency. Our library allows unbiased
selection and optimization of shRNA-encoding sequences that confer phenotypes of interest, and could be used for the
development of therapeutics and tools in many fields of biology.
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Introduction
Small, non-coding RNAs can inhibit gene expression through
interaction with mRNAs in a process called RNA interference
(RNAi) [1]. In the canonical pathway, hairpin-loop microRNAs
(miRNAs) transcribed from the genome are processed by the
ribonucleases Drosha and Dicer into ,22-nucleotide (nt) small-
interfering RNAs (siRNAs). The RNA-Induced Silencing Com-
plex, RISC, uses the siRNAs to cleave and/or inhibit the
translation of complementary mRNAs in a sequence-specific
manner. Transfection of cells with chemically synthesized siRNAs
can produce a transient silencing of appropriately targeted
mRNAs. Expression of short-hairpin-loop RNAs (shRNAs), which
are modeled on miRNAs, can be used for sustained RNAi.
Many endogenous miRNAs target short sequences in the 39
untranslated regions (UTRs) of a large number of mRNAs. Over-
expression of the miRNAs miR-1 and miR-124, for example,
shifted cellular expression profiles to those of muscle and brain,
respectively [2], with apparent targeting to sequences of only seven
and six nucleotides, respectively, in the 39 UTRs of the mRNAs.
Vertebrate miRNA-target interactions are mediated primarily by
‘‘seed’’ matches of six nucleotides (miRNA nucleotides 2–7)
supplemented with either a U at position 1 or a match at position 8
[3]. Hence sequence matches of fewer than eight nucleotides are
apparently sufficient to exert phenotypic effects, likely through
translational repression [4–6]. If the complementarity extends
beyond the 10th nucleotide of the miRNA, target mRNA cleavage
occurs [7,8].
Our understanding of the full range of effects of miRNAs,
shRNAs, and siRNAs is far from complete, and non-canonical
functions are becoming apparent. For example, recent findings
indicate that small RNA species can activate gene expression.
Promoter-targeted siRNAs activated expression of the progester-
one receptor in a sequence-specific manner [9]. Promoter-targeted
siRNAs also activated the genes encoding E-cadherin, p21, and
vascular endothelial growth factor [10]; the seed sequence and
Dicer were required, and the activation was sequence specific.
Three independent miRNAs targeted to the 39 UTRs of three
different mRNAs repressed translation in proliferating cells but
activated translation in cell-cycle-arrested cells; the translational
activation required both FXR1 and AGO2, which exhibited a
miRNA-dependent association with the mRNAs [11].
RNAi is now commonly used as a tool to knock down the
expression of specific genes through rational-design algorithms
targeting specific sequences in mRNAs [12]. RNAi libraries based
on canonical pathways have been developed for screening
purposes. Most of these libraries encode shRNAs and target single
genes with each construct. Some of these libraries focus on
particular pathways or gene-sets of interest [13,14], while others
are broad-based [15,16]. Second-generation libraries have been
constructed in miRNA contexts for improved RNAi effects [17].
In part to decrease costs associated with generating thousands of
individual constructs by rational design, several groups have used
enzyme-based approaches to construct RNAi libraries from either
cDNA or genomic DNA fragments [18–21]. These RNAi libraries
are useful for identifying single genes of biologic interest, or genes
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that encode potential targets for conventional drug development.
However, for identifying shRNAs or siRNAs to be used in and of
themselves as therapeutics or biologic tools, the most effective
sequences may target more than one gene and/or may act through
non-canonical mechanisms. To identify such sequences, libraries
that are random at the nucleotide level, and therefore unbiased
with respect to mechanism of action, are preferable.
One group created a library that uses two opposed promoters to
transcribe linear RNAs from the same 19-base-pair random
sequence simultaneously [22], which may limit transcriptional
efficiency and lead to effects based on antisense. Even assuming
siRNA effects, several limitations remain: 1) siRNAs are less potent
than shRNAs [23,24]; in the context of screening random
libraries, potency is critical since the initial effects are expected
to be weak. 2) The design of siRNA-encoding libraries precludes
mismatches in the RNA duplex, a factor contributing to the
potency of endogenous miRNAs. 3) shRNAs or siRNAs with 27–
29 bp stems are far more potent inducers of RNAi than constructs
with 19–21 bp stems [25,26]; however, siRNAs .23 bp in length
are more likely to induce, non-specific interferon responses [27].
To overcome the limitations of single-gene-targeting shRNA
libraries and the aforementioned random, siRNA-encoding
library, we set out to design, synthesize, and test a random,
shRNA-encoding library. The primary goals of the design were to
allow the expression of random shRNAs with stems of optimal
length (29-nt [25]); to allow the straightforward retrieval of ‘‘hit’’
sequences by PCR and cloning back into the vector; and to allow
mismatches between the two halves of the stem after random
mutagenesis for hit-optimization. The synthetic challenges includ-
ed, 1) creating the reverse complement of a 29-nt random
sequence in the same strand of DNA, 2) creating a non-
complementary loop between them, 3) synthesizing a double-
stranded version of this DNA, and 4) cloning the double-stranded
version into an appropriate vector for robust expression, with a
polymerase termination sequence at the 39 end and a poly-
pyrimidine tract upstream of the transcription start site. Herein we
describe how we solved these technical challenges and used a
functional approach to identify hit sequences that protect an IL3-
dependent cell line from IL3 withdrawal, and how we hit-
optimized by random mutagenesis and re-screening.
Results
Library synthesis and characterization
The synthesis of our random, shRNA-encoding library is
described in detail in the Materials and Methods section and
shown in Figure 1. Figure 1A shows the essential elements of the
double-stranded DNA cassette encoding the random shRNAs.
The sense strand comprises a random 29-nt sequence (‘‘N29’’), a
non-complementary loop sequence, the reverse complement
(‘‘n29’’) of the random 29-nt sequence, and a polymerase III
termination sequence. The rationale for a 29-nt stem comes from
the work of Siolas et al., who showed that shRNA constructs with
29-nt stems and 2-nt 39 overhangs were far more potent inducers
of RNAi than equivalents with 19-nt stems [25]. The construction
of our library requires a fixed base at the 29th position, which we
arbitrarily made a Guanine initially (Figure 1B). This ‘‘N28+G’’
library represents one-fourth of a library encoding shRNAs with
random, 29-nt stems; the other three-fourths could be synthesized
by altering the Guanine at the 29th position to each of the other
three bases in turn. Because Dicer removes the 29th position in
canonical RNAi processing, we opted to proceed with the
construction and testing of the ‘‘N28+G’’ library. Because the
initial library was prepped from ,300,000 E. coli colonies (to
ensure adequate coverage of 48 or 65,536 possible seed sequences),
we refer to it herein as the ‘‘300K library.’’ To rule out significant
sequence bias introduced by any of the steps during synthesis, we
sequenced 40 individual clones, either from the final library or
from the intermediate prior to the creation of the non-
complementary loop. The AT composition was 52.8% (14.78 of
28) and the GC composition was 47.2% (13.22 of 28) (Figure S1B).
The DNA cassette was initially designed for cloning into the
retroviral expression vector pSuper (OligoEngine). We later
transferred the library to pSiren (Clontech), which provided better
expression of green fluorescent protein (GFP). The preparation of
both vectors, and the en bloc move of the library from pSuper to
pSiren, are described in Figure S2.
Selection for shRNAs that inhibit apoptosis
The murine pro-B cell line FL5.12 is IL3 dependent; ,100% of
the cells die by apoptosis after IL3 withdrawal for 2–3 days and
.90% of cells can be rescued by Bcl-xL [28]. We infected
,6 million FL5.12 cells with the library to ,30% GFP positivity.
The rationale for ,30% infectivity was to ensure the delivery ,1
shRNA construct per cell, thereby maximizing the chances of
identifying effective shRNA sequences with even weak effects.
(Most of the shRNAs encoded by the library are presumably
inactive, but could compete with effective sequences for loading
onto RISC.)
After 3 days in IL3-negative medium, surviving cells were
transferred back to regular growth medium with 0.3 ng/ml IL3
for 3 days. To enrich for true positives, we withdrew IL3 again and
the process was repeated. (The mathematics of enrichment
scenarios are shown in Table S1) After four rounds of IL3
withdrawal and recovery, the percentage of GFP-positive cells in
the library-infected wells (but not in the control-infected wells) rose
to 60%, suggesting the presence of hit sequences that conferred a
relative survival advantage (Figure 2A). (We consistently observed
a post-infection decline in the percentage of GFP-positive cells
suggesting that a subset of shRNAs, GFP, and/or the infection
treatment itself were detrimental to the cells). We isolated genomic
DNA, amplified by PCR using pSiren-specific primers flanking the
hairpin-loop insert, and cloned back into pSiren.
Of 10 shRNA-encoding sequences we sequenced, two were the
same (clones ‘‘1p’’ and ‘‘7p’’), suggesting selective enrichment. We
infected FL5.12 cells with three of the putative hit sequences (1p,
3p, and 8p) in six independent infections for each clone and
withdrew IL3 for 14 hours (to allow weak effects to be discerned).
We analyzed the cells by flow cytometry, identifying infected cells
by GFP fluorescence and dead cells by propidium iodide (PI)
staining. The fractions of GFP-positive (infected), PI-negative (live)
cells relative to the start of the experiment (just prior to IL3
withdrawal) are shown in Figure 2B. Clones 1p and 3p conferred a
statistically significant improvement in survival relative to cells
infected with a random control shRNA (‘‘ctrl’’) or with vector
alone (pSiren) (p,0.0001 in each case by Student’s t-test). Clone
8p did not confer protection initially (Figure 2B); however, after
several days of culturing in IL3, 8p conferred protection from IL3
withdrawal similar to that of 1p and 3p (Figure S3, note the longer
starvation time of 22 hours in this assay). All three clones were
tested for effects on growth rate and none were seen (Figure S4).
The sequences of 1p, 3p, and 8p, including the CTAAAC loop,
are:
Clone 1p 59-GGGTAGCTACATTTGCATATGTGGATATG CTAAA-
C CATATCCACATATGCAAATGTAGCTACCC-39
Clone 3p 59-GTGGATCAGTGTGTTATAGCTCGGGCAGG CTAAA-
C CCTGCCCGAGCTATAACACACTGATCCAC-39
Random shRNA-Encoding Library
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Clone 8p 59-GGCGGCGGCAAGGAAGGCATTGAGGACTG CTAAA-
C CAGTCCTCAATGCCTTCCTTGCCGCCGCC-39
Longer IL3 withdrawal times were associated with lower survival
percentages, but the hit shRNAs consistently conferred approxi-
mately double the survival relative to a control random shRNA or
empty vector (see figures 2B, 3C, 4B, 4D, 5B, and S3, S5, which
show survival percentages assayed at 14–22 hours). The protective
effects of 1p, 3p, and 8p upon IL3 withdrawal were largely intact
after continuous culture for four months in IL3-containing medium,
and a random sample of 10 individual clones from the 300K library
failed to protect FL5.12 cells from IL3 withdrawal (Figures S5 and
S6). Because FL5.12 cell death after IL3 withdrawal is apoptotic, we
tested whether the protective effects of the hit shRNAs were
Figure 1. Synthesis of the random shRNA library. (A) Schematic diagram of the DNA cassette encoding the shRNA transcript, where N and n
indicate complementary bases. (B) The steps of library synthesis (see Materials and Methods for details). Step 1: Extension using oligo (1) as primer
and oligo (2) as template. The underlined mismatches create an intact AarI site and mutated PmeI site in the oligo (2). The letter ‘‘s’’ in oligo (2)
indicates a phosphorothioate linkage. Step 2: Ligation to short hairpin-loop (3). Step 3: Digestion of one strand by nicking enzyme Nb.BbvCI. Step
4: Opening of the large hairpin-loop by extension using strand-displacing polymerase Bst, and additional oligo (4) as primer. Step 5: Digestion with
BtgZI, which cuts downstream of its recognition site at one end, but not the other, because of the phosphorothioate linkages. Step 6: Fill-in of the
BtgZI-cut end and digestion by NotI of the other end. Step 7: Cloning of the blunt-NotI cassette into an shRNA-expression vector, and transformation
into E. coli, which replace the phosphorothioate linkages with normal phosphodiester linkages. Step 8: Asymmetric digestion with PmeI and AarI,
because of the designed mismatches between the first primer (1) and the original template oligo (2). Step 9: Fill-in of the AarI end and unimolecular
blunt-blunt ligation, resulting in an asymmetric loop sequence.
doi:10.1371/journal.pone.0003171.g001
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Figure 2. Selection for shRNAs that protect FL5.12 cells from IL3 withdrawal. (A) GFP percentages of FL5.12 cells infected with a random-
shRNA-expressing control or the 300K library and subjected to repeated IL3 starvation/recovery (3day/3day) cycling. The GFP percentages are shown
post infection (infc) and after each recovery (Rec). (B) Survival percentages (percentages of GFP+/PI2 cells) shown are relative to the beginning of IL3
starvation. Three shRNA constructs – 1p, 3p, and 8p – were tested against a random shRNA control or empty vector (pSiren) in FL5.12 cells starved for
14 hours. By Student’s t-test, we found p,0.001 for 1p and 3p vs. controls. Data are means +/2 standard deviations (SD). 8p offered similar ,26
protection relative to control when tested several days later (Figure S3). (C) Caspase 3 activities of cells infected with 1p, 3p, 8p compared to control
shRNA and pSiren at 12 hours of IL3 starvation. By Student’s t-test, we found p=0.031 for 1p vs. control, and p,0.001 for 3p and 8p vs. control. Data
are means +/2 SD.
doi:10.1371/journal.pone.0003171.g002
Random shRNA-Encoding Library
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associated with a decrease in the activity of caspase 3. Caspase 3
activity was markedly decreased in cells infected with 3p and 8p, but
less so in cells infected with 1p (Figure 2C, p=0.031 for 1p vs
control, and p,0.001 for 3p and 8p vs control). Using BLAST, and
readily available miRNA target predicting software (miRGen,
miRanda, TargetScan, and MiRScan), we were unable to identify
convincing targets for 1p, 3p, or 8p.
Hit-optimization
We created random variants of the 3p shRNA sequence using
an oligo synthesizer and spiking each phosphoramidite (A, C, G,
T) bottle with the other three (‘‘spiked oligo synthesis’’) [29] at a
low concentration designed to generate ,1.5 mutations per
construct after annealing the two complementary DNA strands.
These mutations could occur anywhere in the cloning cassette,
including the stem, the loop, and sequences outside the stem-loop.
We cloned these 3p variants into pSiren to create a sublibrary.
Because approximately 3000 clones are needed to cover 1.5
mutations on average, we harvested ,10,000 E. coli colonies for
the sublibrary, which we named sublibrary 9.1.
We introduced sublibrary 9.1, 3p, and a random control
shRNA into FL5.12 cells by retroviral infection, and subjected the
cells to cycles of IL3 ‘‘starvation and recovery’’ just as with the
original library except that we increased the stringency of selection
by extending the length of the IL3 starvations. The first starvation-
recovery cycle comprised three days of IL3 starvation and three
days of recovery (S3R3); the second comprised five days of IL3
starvation and eight days of recovery (S5R8) (Figure 3A). Neither
the cells infected with a random control shRNA nor the cells
infected with 3p survived the second cycle. After the third cycle,
the cells were subjected to either four- or five-day starvations, and
the clones recovered were called sub-library 9.1a and 9.1b,
respectively. The percentage of GFP-positive cells rose sharply to
70% after the fourth cycle, and to .85% after the fifth cycle
(Figure 3A). Of 10 shRNA-encoding sequences we retrieved from
sublibrary 9.1b after the fifth cycle, eight were identical, suggesting
selective enrichment (Figure 3B). We tested whether one of the
eight identical clones (‘‘3p05p’’) was more efficacious than 3p at
protecting FL5.12 cells from IL3 withdrawal, except that we
determined percent survival after 22 hours of IL3 withdrawal
rather than after 14 hours. 3p05p significantly improved survival
relative to 3p, and 3p was still approximately twice as protective as
control (Figure 3C, p=0.014 for 3p05p vs 3p, and p,0.01 for 3p
vs control).
There are three nucleotide differences between 3p05p and 3p,
which introduced both sequence changes and mismatches between
the two halves of the stem. We therefore synthesized variants of
3p05p, each of which has only one of the three nucleotide changes
(Figure 4A), and quantified their activities in protecting FL5.12
cells from IL3 withdrawal. The variant with the A-to-C change,
MCp, was more protective than 3p (p,0.0001), and was nearly as
protective as 3p05p, whereas the activities of the other two variants
(MTp and MAp) were less than that of 3p (Figure 4B, p,0.0001
for each). These results suggest that the A-to-C change accounts
for most of the improved effect of 3p05p, and that the effect of one
or both of the other two nucleotide changes depends on sequence
context. The beneficial C of MCp (Figure 4A) creates a mismatch
with the other half of the (3p) stem.
To test whether the mismatch per se, or the presence of the
specific nucleotide C, contributed to the improved activity, we
synthesized and tested two additional variants. In one variant (clone
‘‘G-C’’), we maintained the nucleotide C of MCp, but eliminated
the mismatch by placing a complementary G in the other half of the
stem. In the other variant (clone ‘‘C-T’’), we changed the critical
nucleotide C to a T but maintained the same mismatch as that
found in MCp by placing a non-complementary C in the other half
of the stem (Figure 4C). The improved activity of MCp (T-C)
relative to 3p (T-A) was abolished by the alteration in clone G-C, as
well as by the alteration in clone C-T (Figure 4D, p,0.001 for both),
suggesting that both the mismatch and the presence of the specific
nucleotide C contributed to the improved activity.
We also synthesized and tested variants of 3p05p (Figure 5A) in
which we eliminated the three mismatches by altering the
corresponding nucleotides on the opposite half of the stem
(NoMMp), or in which we retained the three mismatches but
changed each of the two new pyrimidines in 3p05p to a different
pyrimidine and the new purine to a different purine (3Mp). The
activity of 3p05p was abolished in both variants, though more so in
the NoMMp clone (Figure 5B), again suggesting the importance of
mismatches (though we cannot rule out that the complementary
base changes in the other half of the stem in NoMMp affected
processing by Dicer or loading onto RISC).
Discussion
A potential limitation of the random shRNA approach is that
there are approximately 18 trillion (422) random 22-nt sequences
that could be loaded onto RISC. Selection assays using 18 trillion
cells are infeasible, and multiple sequences introduced into
individual cells would compete with each other for loading onto
RISC. Hence, only a fraction of the total possible 22-mer sequences
can be interrogated. What makes the random approach viable, at
least for the canonical RNAi pathway, is the importance of the seed
match in target interactions. Infection and analysis of several million
cells is straightforward, yet interrogation of only ,65,500 random
shRNAs ensures a U at position 1 and a match at positions 2–7 and a
match at position 8. The critical factors in the random approach are
to ensure that, at a minimum, all possible seed matches are covered,
and to ensure that the potency of the constructs is maximized;
shRNAs that match only seed sequences may produce only weak
effects, but can be hit-optimized by random mutagenesis and re-
screening, as evidenced by the data herein.
The primary advantage of the random shRNA approach is that
it is unbiased with respect to mechanism(s) of action, of which our
understanding remains incomplete. It is of interest to note that in
the mutagenesis study (Figure 4), the critical ‘‘C’’ mutation
occurred at the 39 end of the shRNA, outside the ‘‘seed region,’’
and the ‘‘T’’ mutation, which made MTp even less active than 3p,
occurred outside the canonical 22-mer sequence of a mature
miRNA. Taken together, these results not only point to the
importance of both sequence specificity and mismatches between
stems in the activity of shRNAs, they also illustrate the power of
our library design and mutagenesis approach to select for the most
active shRNAs in an agnostic manner. For shRNA-based
therapeutics or biologic tools, the most effective sequences may
target more than one gene and/or may act through non-canonical
mechanisms. After infection or transfection with a random
shRNA-encoding library, cells with a desired phenotype can be
selected functionally (by survival or flow-sorting, for example), and
effective sequences can be retrieved by PCR. In effect, we allow
the cells to determine which sequences are the most effective, and
the least toxic, without prior assumptions.
For functional selection, our random, shRNA-encoding library
has specific advantages over the random, siRNA-encoding library
that has been described [22]. In addition to the advantages
described in the introduction, we have demonstrated herein the
importance of mismatches in contributing to the potency of RNA
duplexes; the design of the siRNA library precludes mismatches
Random shRNA-Encoding Library
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because the siRNAs are encoded by opposing DNA strands and
thus are eliminated in E. coli during cloning. The combined
benefits of shRNAs over siRNAs are critical for random-library
screens, in which initial hits are expected to be weak. The shRNAs
encoded by our library more closely resemble endogenous
miRNAs, and, as such, maximize chances for success.
Our unbiased, functional approach complements existing RNAi
libraries, which target single genes. Single-gene targeting is well
suited for traditional drug development, since the encoded protein
might be targeted using small molecules, which involves an
additional screening process, followed by synthetic chemistry and
re-screening for hit-optimization. Our approach is designed to
identify sequences that can be used as therapeutics or biologic tools
in and of themselves. In this regard, hit-optimization through
random mutagenesis is significantly easier than the synthetic
chemistry required to modify small molecules in traditional hit
optimization. Although initial hits from single-gene-targeting
RNAi libraries may be more potent than initial hits from our
library, the number of target genes for the most potent miRNAs is
thought to be in the hundreds, suggesting that shRNA potency for
inducing a specific phenotype may derive from altering the
expression of a large number of genes partially, instead of altering
Figure 3. Hit-optimization of 3p. (A) GFP percentages of FL5.12 cells infected with sublibrary 9.1, which was synthesized by random mutagenesis
of the sequence of 3p. FL5.12 cells were subject to extended IL3 starvation/recovery cycles; ‘‘SxRy’’ represents Starvation for x days and Recovery for y
days. After the third cycle, the cells were subjected to either four- or five-day starvations, and the clones recovered were called sub-library 9.1a and
9.1b, respectively. (B) Sequences of ten clones from sublibrary 9.1b retrieved from FL5.12 cells surviving extended IL3 withdrawal. (C) Survival
percentages (percentages of GFP+/PI2 cells) are shown for cells infected with 3p05p, 3p, and a random control shRNA (ctrl), after 22 hours of IL3
starvation. By Student’s t-test, we found p= 0.014 for 3p05p vs. 3p, and p,0.01 for 3p vs. control. Data are means +/2 SD.
doi:10.1371/journal.pone.0003171.g003
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Figure 4. Sequence variation outside the ‘‘seed’’ region as well as mismatches are important for protection from apoptosis. (A)
Sequences of three single-mutation variants of 3p based on the sequence of 3p05p. (B) The A-to-C mutation accounts for most of the improved
activity relative to 3p. Survival percentages (percentages of GFP+/PI2 cells) are shown for cells infected with 3p05p, 3p, a random control shRNA
(ctrl), and three single-mutation variants of 3p based on the sequence of 3p05p, after 20 hours of IL3 starvation. Among the variants, only 3p05pMCp
is more protective than 3p (p,0.0001); the other two variants (MTp, and MAp) are less protective than 3p (p,0.0001 for both). Data are means +/2
SD. (C) Sequences of two additional variant clones: C-T and G-C. (D) Increased activity of MCp (T-C) over 3p (T-A) (p = 0.002) was abolished by either
variant C-T (nucleotide ‘‘C’’ changed, but mismatch retained) or G-C (‘‘C’’ retained, but mismatch eliminated) (p,0.001 for both). Data are means +/2
SD.
doi:10.1371/journal.pone.0003171.g004
Figure 5. Variants of 3p05p abolish its activity and suggest the importance of mismatches and sequence specificity. (A) Three
nucleotides were changed in 3p to form 3p05p (T-A-C), thus introducing mismatches between the two halves of the stem. Clone 3Mp was designed
to maintain the three mismatches, but by changing T-A-C to C-G-T. Clone NoMMp was designed to keep the T-A-C, but to eliminate the mismatches
by altering the corresponding nucleotides on the other half of the stem to G-T-A. (B) FL5.12 cells were transduced with the shRNA clones shown, and
subjected to IL3 withdrawal for 20 hours. Both variants of 3p05p lost their protective activities, to a level even lower than that of 3p. (p,0.001 for any
pair-wise comparisons in the figure) Data are means +/2 SD.
doi:10.1371/journal.pone.0003171.g005
Random shRNA-Encoding Library
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the expression of a single gene considerably. A possible reason for
this increased potency is the tendency for cells to compensate
homeostatically for a significant change in the expression of a
single gene. Particularly in the context of tissue identity and
differentiation, the miRNA paradigm [2] indicates that targeting
multiple genes is often more effective to achieve a particular
phenotype. In addition, our library allows for the exploration of
non-canonical mechanisms not addressed by existing libraries.
It is unsurprising that we were unable to identify convincing
targets for our shRNAs using target-identification algorithms such
as BLAST, miRGen, miRanda, TargetScan, and MiRScan. The
sequence space we were interrogating comprised an entire genome,
and the shRNA sequences we identified were selected from a
random library, are unlikely to exist in nature, and may act by non-
canonical mechanisms. In addition, given the miRNA paradigm,
the shRNA sequences we identified are likely to have many targets
and are likely to have mismatches with some or all of their canonical
targets. As our knowledge increases – of the mechanisms of action of
shRNAs and of the sequence rules governing these mechanisms of
action – it may be possible to identify critical targets of shRNAs
selected functionally from our library. Microarray analyses of cells
expressing these shRNAs might help by narrowing the sequence
space to be interrogated using improved target-identification
algorithms to the set of genes whose expression changes
significantly, though these changes may derive from direct or
indirect actions of the shRNAs. In many cases, identification of the
most critical targets may be problematic. However, our primary
goal in developing a random, shRNA-encoding library was to
identify potential shRNAs to be used as therapeutics and biologic
tools, rather than potential targets for conventional drug develop-
ment. For applications in which transient or reversible effects are
need, shRNA sequences identified and optimized by our approach
could be used as siRNAs.
For shRNA and siRNA therapeutics, issues of delivery to
specific tissues remain [30], but are increasingly being solved. For
example, Kumar et al. used a 29-residue peptide from the rabies
virus glycoprotein envelope to deliver siRNAs from the blood-
stream specifically to neurons, thereby protecting mice against
subsequent Japanese encephalitis virus infection [31]. Several
companies are already involved in clinical trials of RNAi
therapeutics [32], including Acuity (age-related macular degener-
ation, diabetic retinopathy), Alnylam (respiratory syncytial virus),
and Merck (age-related macular degeneration, hepatitis C). Our
random shRNA approach has potential applications in a variety of
systems, including protection against viral infection (by retrieving
shRNAs from surviving cells) and stem-cell differentiation (by flow-
sorting cells with specific surface markers). Our study may serve as
a proof of principle for these applications.
Materials and Methods
Library synthesis (Figure 1B)
All oligos from this section were made by IDT Inc., and all
enzymes were obtained from New England Biolabs. We started by
annealing a short primer (1) to a 97-nt oligo (2). The 97-nt oligo
contains a 29-nt random sequence (N29) and multiple enzyme sites
necessary for later steps. The oligo also contains five phosphor-
othioate linkages (indicated by the letter ‘‘s’’) separating the last
three A residues and the first three random residues. The 29-nt
random sequence (N29) ends, in this case, with a G, so the library
made from this particular oligo (N28+G) comprises one fourth of a
complete, random N29 library. The primer (1) has two mismatches
with respect to the oligo (2), designed to preserve the PmeI
recognition sequence in the 97mer (2) and the AarI recognition
sequence in the primer (1). Step 1: A single extension was carried
out with Klenow enzyme at 37uC for 30 min. Step 2: The
extension product was ligated to a hairpin-loop linker (3) with T4
DNA ligase at 15uC overnight. Step 3: The ligated hairpin-loop
was digested with Nb.BbvCI, a nicking enzyme that cuts only one
strand of DNA; this created an ‘‘exposed’’ area on the stem for
annealing of the second primer (4). Step 4: The nicked hairpin-loop
was ‘‘opened up’’ with the strand-displacing polymerase Bst at 65uC
for 30 min, with a 10-fold molar excess of primer (4). Step 5: The
product was digested with BtgZI, which cuts downstream of its
recognition site. The BtgZI digestion was asymmetric because of the
undigestible phosphorothioate linkages we designed. Step 6: The
recessed end after BtgZI digestion was filled in with Klenow to form
a blunt end, and the other side was digested with NotI. Step 7: The
DNA cassette was blunt-NotI ligated into an appropriately modified
expression vector pSuper (Oligoengine). Step 8: PmeI and AarI were
used to digest the loop sequence; because of designed mismatches
between primer (1) and the 97-nt oligo (2), PmeI cut on one side of
the loop sequence and AarI on the other. Step 9: The recessed end
after AarI digestion was filled in with Klenow to form a blunt end,
and the vector was re-closed with a unimolecular, blunt-blunt
ligation using T4 DNA ligase at 15uC overnight.
Random Mutagenesis
Random mutagenesis of the 3p sequence was carried out on a
PCR-MATE EP 391 DNA synthesizer (ABI biosystems) in our own
laboratory. The manufacturer’s instructions were followed, except
that for each phosphoramidite bottle – A, G, C or T – small
amounts of the other three phosphoramidites were spiked in. For
example, if a 1% mutation rate were desired, then 1% of C, G, and
T phosphoramidites would be mixed with 99% A. If C, G, and T
incorporated into the oligo at equal efficiency, then 0.33% of each
would be used. However, we adjusted for differences in incorpo-
ration efficiency (A=20%, G=26%, C=24%, T=30%). For our
synthesis we aimed at 2 mutations per oligo, which comprised an
87-mer hairpin-loop structure plus flanking sequences. So the three
‘‘mutation’’ phosphoramidites were added for a combined total of
2.3% (2/87). The 87-mer sequences used to synthesize mutants of
3p were: 59-GATCTCC-GTGGATCAGTGTGTTATAGC-
TCGGGCAGGCTAAACCCTGCCCGAGCTATAACACACT-
GATCCAC-TTTTTCAGGTCATCGC-39; 59- GGCCGCGAT-
GACCTGAAAAA-GTGGATCAGTGTGTTATAGCTCGGGC-
AGGGTTTAGCCTGCCCGAGCTATAACACACTGATCCA-
C-GGA-39. (Loop sequences are underlined, and the shRNA-
encoding cassette is separated from the flanking sequences with a
dash.) The synthesized oligos were purified using an oligo
purification cartridge, per ABI instructions. Since the oligos have
a strong propensity to form intramolecular hairpin-loop structures,
we annealed the two oligos by mixing them at equal molar ratios
and then renatured in a step-wise process using a PCR machine:
95uC630 sec, 72uC62 min, 37uC62 min, and 25uC62 min,
followed by an incubation at 4uC. The annealed oligos were then
phosphorylated with T4 kinase, and cloned into pSiren prepared
with BglII and NotI and dephosphorylated with Shrimp Alkaline
Phosphatase (Roche).
Cell culture, retroviral transduction
The FL5.12 pro-B cell line was a gift from Dr. Craig Thompson
(University of Pennsylvania). FL5.12 cells were cultured in RPMI
1640 media with 10% FBS (BioWhittaker), 10 mM Hepes pH 7.4,
100 U/ml Penicillin, 100 mg/ml Streptomycin, 55 mM b-Mer-
captoethanol (all from Gibco), supplemented with 0.3 ng/ml IL3
(BD Pharmingen). To prepare retroviral supernatant for infection,
293T cells growing at ,60% confluency were transfected with
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Effectene reagent (Qiagen) according to manufacturer’s instruc-
tions. The pSiren library was co-transfected with an ecotropic
retroviral packaging plasmid pCL-Eco (Imgenex) at a dose of
2.5 mg total DNA per well in a 6-well plate. Supernatant was
harvested to infect FL5.12 cells with 3 cycles of centrifugation
(1000 g61 hr) and incubation (2 hrs), in the presence of 5 mg/ml
polybrene (Sigma). Infection efficiency was monitored by GFP
expression on a BD FACSCalibur flow cytometer. Ideally the
GFP% was kept at ,33% or less whenever a library was used to
transduce cells, such that, by Poisson distribution, the majority of
the infected cells received only one construct.
Sequence retrieval and confirmation
To retrieve shRNA-encoding sequences integrated in the
genome, cells that have been enriched for GFP after IL3
starvation/recovery cycles were pelleted, and their genomic DNA
was extracted using a Qiagen kit. The shRNA-encoding cassette
was amplified from genomic DNA using the following protocol:
95uC65 min, 95uC/56uC/72uC at 30 s/45 s/10 min for 30 cycles,
with primers flanking the shRNA-encoding cassette on pSiren. The
sequences of the primers are 59-CCGGAATTGAAGATCTGGG-
39 and 59-CCGTAATTGATTACTATTAATAACTAGAATTC-
39. The long extension time (10 min) was necessary due to the
hairpin structure of the template. To sequence the hairpin-loop
structure we developed two sets of primers that amplify the two
halves of the hairpin separately. To amplify the 59 half of the stem,
we used one primer upstream of the cassette and a second primer
that comprises the loop sequence at its 39 end and sequences
downstream of the cassette at its 59 end (thus ‘‘jumping over’’ the 39
half of the stem). The sequences of these two primers are: upstream
59-CCCCCTTGAACCCTTTATCC-39 and downstream 59-
CGATGACCTGAAAAAGGTTTAGC-39. The sequence of the
39 half of the stem was obtained in a similar fashion; the primers
were 59-GGGCGTACTTGGCATATG-39 and 59-GACG-
GATCTCCGCTAAACC-39. Conditions for these so-called
‘‘half-shRNA’’ PCR amplifications were: 95 C65 min, 95uC/
52uC/72uC at 30 s/45 s/5 min for 40 cycles.
Apoptosis induction and caspase 3 assay
Apoptosis was induced in FL5.12 cells by washing 36with IL3-
negative medium and resuspending in IL3-negative medium. To
replenish IL3 for recovery, IL3 was simply added back to the
medium at 0.3 ng/ml. Tests of individual shRNAs were carried
out with an overnight IL3 starvation of 14–22 hours. Cells were
then stained with 20 mg/ml propidium iodide (PI, Sigma) in the
presence of 0.2 mg/ml of RNAse A (Roche). The percentage of
GFP-positive (infected), PI-negative (live) cells relative to the start
of the experiment (just prior to the IL3 withdrawal) were
determined by flow cytometry on a BD FACSCalibur. Caspase
3 was assayed using an enzyme activity kit (BIOMOL) according
to manufacturer’s instructions, by measuring the cleavage of a
colorimetric substrate, Ac-DEVD-pNA.
Statistical analysis
Pair-wise comparisons of means were conducted using Student’s
t-test. Error bars represent standard deviations. The data points
for each bar graph were determined from 3 to 6 independent
experiments.
Supporting Information
Table S1 Enrichment for true-positive shRNA sequences after
various rounds of selection and re-screening, assuming a true
positive rate of only 1 in 1 million, false positive rates of either 1%
(left) or 10% (right), and no heritability of false positives.
Found at: doi:10.1371/journal.pone.0003171.s001 (0.03 MB
DOC)
Figure S1 Sequencing data of the random library. (A)
Sequencing results from the shRNA library before the creation
of the non-complementary loop. At this stage, PmeI digest allowed
the two halves of the stem to be separated and sequenced more
easily. The electropherogram confirms all features of the cassette
design. (B) Sequences of 40 random clones from the library. Note
the last base is a G for all sequences, as discussed in the main text.
In a perfectly random scenario, therefore, there should be 14 A/Ts
and 15 G/Cs. The 40 clones showed a distribution of 14.78 A/Ts
and 14.22 G/C, on average. Thus there is a very slight bias
towards A/T. No obvious patterns in these sequences can be
discerned.
Found at: doi:10.1371/journal.pone.0003171.s002 (0.16 MB TIF)
Figure S2 Vector preparation for cloning of the shRNA-
encoding cassette. (A) The cassette was initially designed for
cloning into pSuper (Oligoengine); shown here are the steps used
to prepare pSuper for blunt-end/NotI cloning. A linker containing
the BbsI site was cloned into pSuper cut with BglII and MluI. The
linker also contained the SnaBI site for the purpose of checking the
ligation since there is another SnaBI site in pSuper. The altered
pSuper was then digested with BbsI, which is a downstream cutter,
and then filled-in with Klenow to form blunt ends on both sides.
BbsI was positioned precisely on the linker, such that after the
digest and fill-in, the blunt end is at the correct distance from the
promoter per the manufacturer’s instructions. The blunt-blunt
vector was then cut with NotI to form the blunt-end/NotI pSuper,
ready for ligation of the shRNA-encoding cassette (Figure 1B) (B)
Transfer of the library en bloc into pSiren (Clontech) to ensure
consistent GFP expression after retroviral infection and integra-
tion. The standard restriction sites for cloning into pSiren are
BamHI and EcoRI. We introduced a NotI site between the
BamHI and EcoRI sites using a primer with all three sites in the
correct order. This primer also mismatches the pSiren template by
‘‘jumping over’’ two bases highlighted in the figure. These two
bases needed to be eliminated because the cassette excised from
pSuper with BglII-NotI had two extra bases, ‘‘CC,’’ after the BglII
site (see part (A)). Therefore, paired with an appropriate upstream
primer, we introduced a NotI site and eliminated two bases in
pSiren. The modified vector was then cut with BamHI and NotI,
and was ready to accept the BglII-NotI cassette from pSuper, with
the correct spacing from the PolIII promoter. Note that BamHI
and BglII have compatible cohesive ends. The two primer
sequences are: ‘‘RINotBam’’ 59-CTTGAATTCGCGGC-
CGCTTGGATCCGTCCTTTCCACAAG-39, and ‘‘SirenBgl’’
59-CCGGAATTGAAGATCTGGG-39.
Found at: doi:10.1371/journal.pone.0003171.s003 (0.08 MB TIF)
Figure S3 8p offers delayed protection of FL5.12 cells from IL3
withdrawal. Initially, 8p did not offer protection (Figure 3), but its
effect became apparent one week later. Survival percentages were
obtained in the same manner as for all other survival figures, after
IL3 starvation of 22 hours in this experiment. (p = 0.019 for 1p vs.
ctrl, p,0.01 for 3p or 8p vs ctrl) Data are means +/2 SD.
Found at: doi:10.1371/journal.pone.0003171.s004 (0.04 MB TIF)
Figure S4 1p, 3p and 8p do not offer FL5.12 cells a growth
advantage. Cells were infected with 1p, 3p, 8p, or pSiren and
compared with cells infected with the same random control
shRNA (ctrl). GFP% was 20–25% after the infections. Cells were
then seeded at 500,000/2 ml (relative cell number = 1) in a 12-
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well plate and allowed to grow for three days. None of the three hit
shRNAs offered any growth advantage over the random control
shRNA. The growth rate was also comparable to the GFP-
negative cells in the same culture. Data are means +/2 SD.
Found at: doi:10.1371/journal.pone.0003171.s005 (0.06 MB TIF)
Figure S5 Effects of the hit shRNAs are long lasting. Cells were
cultured in IL3+ media continuously for 4 months. IL3 was then
withdrawn for 20 hours, and protective effects were still seen
(p = 0.0087 for 1p vs. ctrl, p = 0.073 for 3p vs. ctrl, p = 0.012 for 8p
vs. ctrl). Data are means +/2 SD.
Found at: doi:10.1371/journal.pone.0003171.s006 (0.02 MB TIF)
Figure S6 10 random clones offered no protection. FL5.12 cells
were transduced with 10 additional random clones from the 300K
library, along with pSiren, or the 300K library itself. IL3 was
withdrawn for 15 hours, and the survival percentage was similar in
all cases. A positive control was not included in this experiment;
however, we have performed such starvation assays more than 50
times under different conditions, and the survival percentages
shown in this figure are seen consistently. Data are means +/2
SD.
Found at: doi:10.1371/journal.pone.0003171.s007 (0.03 MB TIF)
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